Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Redcare Pharmacy NVXSWX:RDC -2.03%46 3-Year EPS without NRI Growth Rate is 23.50% as of Jun. 2026. GuruFocus rates XSWX:RDC with a GF Score™ of 46/100 and a GF Value™ of CHF159.85 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 506 Healthcare Providers & Services companies, Redcare Pharmacy NV ranks better than 65.02% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was 23.50% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 1.70% per year.
During the past 10 years, the average EPS without NRI Growth Rate was -2.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Redcare Pharmacy NV was 23.50% per year. The lowest was -86.80% per year. And the median was -12.75% per year.
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Redcare Pharmacy NV 3-Year EPS without NRI Growth Rate Related Terms
For the Pharmaceutical Retailers subindustry, Redcare Pharmacy NV's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Redcare Pharmacy NV 3-Year EPS without NRI Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Redcare Pharmacy NV's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Redcare Pharmacy NV's 3-Year EPS without NRI Growth Rate falls into.
Redcare Pharmacy NV 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 23.50% mean?
Redcare Pharmacy NV (XSWX:RDC) has a 3-Year EPS without NRI Growth Rate of 23.50% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Redcare Pharmacy NV and its competitors. According to the industry distribution chart, Redcare Pharmacy NV ranks #177 out of 506 companies in the Healthcare Providers & Services industry, placing it in the top 35%.
Is Redcare Pharmacy NV's 3-Year EPS without NRI Growth Rate too high?
Redcare Pharmacy NV's current 3-Year EPS without NRI Growth Rate is 23.50%. The Healthcare Providers & Services industry median 3-Year EPS without NRI Growth Rate is 11.05. Redcare Pharmacy NV's value of 23.50% is 112.7% above this industry median. Based on the distribution chart, Redcare Pharmacy NV ranks #177 out of 506 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Redcare Pharmacy NV has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Redcare Pharmacy NV's 3-Year EPS without NRI Growth Rate compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Redcare Pharmacy NV ranks #177 out of 506 companies for 3-Year EPS without NRI Growth Rate. This puts Redcare Pharmacy NV in the upper half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 11.05. Redcare Pharmacy NV's value of 23.50% is 112.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EPS without NRI Growth Rate among Healthcare Providers & Services companies is 11.05, based on 506 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Redcare Pharmacy NV's current 3-Year EPS without NRI Growth Rate of 23.50% is 112.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Redcare Pharmacy NV and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EPS without NRI Growth Rate is 11.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Redcare Pharmacy NV's current 3-Year EPS without NRI Growth Rate is 23.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redcare Pharmacy NV stock overvalued right now?
Based on GuruFocus' analysis, Redcare Pharmacy NV (XSWX:RDC) is currently considered Possible Value Trap. The stock's GF Value™ is CHF159.85, compared to a current price of CHF58.05 — trading 63.7% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 23.50% and 112.7% above the Healthcare Providers & Services industry median of 11.05. Redcare Pharmacy NV's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Redcare Pharmacy NV (XSWX:RDC), the current 3-Year EPS without NRI Growth Rate is 23.50% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Redcare Pharmacy NV (XSWX:RDC) Overvalued in 2026?
Based on GuruFocus' analysis, Redcare Pharmacy NV stock appears to be undervalued.
The current stock price of CHF58.05 is trading 63.7% below its estimated GF Value™ of CHF159.85.
GuruFocus considers Redcare Pharmacy NV to be Possible Value Trap.
Key valuation signals for XSWX:RDC:
3-Year EPS without NRI Growth Rate: 23.50%
GF Value™: CHF159.85 vs. price of CHF58.05 (63.7% below fair value)
Industry Position: 112.7% above the Healthcare Providers & Services median (#177 of 506)
No single metric tells the full story. See the XSWX:RDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Redcare Pharmacy NV is an online pharmacy business for prescription and nonprescription (over-the-counter) pharmaceuticals, beauty and personal care products (BPC) and food supplements. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands. It operates in two segments, namely DACH segment that includes sales in Germany, Austria and Switzerland; and the International segment that includes sales across Belgium, the Netherlands, France and Italy. The DACH segment accounts for the majority of the revenue.
46GF Score
Get the complete analysis for XSWX:RDC
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:RDC has been successfully added to your 
